Drawing for COMPLETEPEAKING

USPTO serial 99404835

COMPLETEPEAKING

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
HOSPERS, ELKIN M
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Deadline: November 12th, 2026

Need help with COMPLETEPEAKING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,220*

Plus Government fees of $625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable decoder software; Downloadable speech recognition software; Downloadable software for machine learning for use in robots; Downloadable computer software using machine learning for creating data models; Downloadable computer software using machine learning for developing predictive models; Downloadable machine learning software for enabling computers to learn to perform tasks autonomously; Downloadable software using machine learning for disease diagnostics; Downloadable optimisation software for disease diagnostics; Recorded optimisation software for disease diagnostics; Downloadable computer software using artificial intelligence (AI) for disease diagnostics; Recorded computer software using artificial intelligence (AI) for disease diagnostics; Downloadable computer programs using artificial intelligence (AI) for disease diagnostics; Recorded computer programs using artificial intelligence (AI) for disease diagnostics; Recorded computer software using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method development; Downloadable computer programs using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method development; Recorded computer programs using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method developmentACTIVE—
010Medical diagnostic apparatus for detecting multiple diseases with embedded operating Software in a Medical Device (SiMD); Medical diagnostic apparatus for testing multiple diseases incorporating recorded software for clinical diagnostics, mass spectrometry, detection method development, and biomarker quantification; Medical diagnostic apparatus for testing multiple diseases incorporating recorded operating system softwareACTIVE—
042Biotechnology research; Customizing computer software; Computer software development; Developing computer software; Computer software consultation; Computer software design, computer programming, and maintenance of computer software; Maintenance of computer software; Updating of computer software; Updating of smartphone software; Copying of computer software; Software design and development; Design and development of software for machine learning; Research in the field of software for machine learning; Design and development of computer software for machine learning; Computer technology consultancy in the field of machine learning; Design and development of computer software for unsupervised machine learning; Design and development of computer software for statistical machine learning; Research in the field of computer software for machine learning; Research in the field of computer software for unsupervised machine learning; Research in the field of computer software for statistical machine learning; Providing online non-downloadable software using artificial intelligence (AI) for machine learning; Software as a service (SAAS) services featuring machine learning software for enabling computers to learn to perform tasks autonomously; Providing online non-downloadable machine learning software for enabling computers to learn to perform tasks autonomously; Providing online non-downloadable software using machine learning for disease diagnostics; Software as a service (SAAS) services featuring software using machine learning for disease diagnostics; Application service provider (ASP) featuring software using artificial intelligence (AI) for disease diagnostics; Providing a website featuring non-downloadable software using artificial intelligence (AI) for disease diagnostics; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for disease diagnostics; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for disease diagnostics; Providing on-line non-downloadable software using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method development; Application service provider (ASP) featuring software using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method development; Providing a website featuring non-downloadable software using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method development; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method development; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method development; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method development; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for clinical diagnostic analysis, including peak picking, biomarker quantification, and method development; Scientific and technological services, namely, research and development in the field of clinical diagnostics, mass spectrometry, detection method development, and biomarker quantification; Scientific and technological services, namely, research and design in the field of clinical diagnostic testing; providing medical diagnostic information based on analysis of mass spectrometer data; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applicationsACTIVE—
044Medical diagnostic testing, monitoring and reporting services; Medical diagnosis and treatment of diseasesACTIVE—
045Licensing of computer softwareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
May 12, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 17, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 20, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2026DOCKASSIGNED TO EXAMINER—
Feb 9, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 21, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance